Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 62175-617

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 62175-617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Pantoprazole Sodium Delayed Release Tablets 1)

FDA Label Image

20 mg (Pantoprazole Sodium Delayed Release Tablets 2)

20 mg (Pantoprazole Sodium Delayed Release Tablets 2)
This is a description of a medication called Pantoprazole Sodium in tablet form. The container of tablets has an NDC number of 6217561846 and contains 90 tablets. Each tablet has a strength of 20 mg Pantoprazole, and is a delayed-release tablet that must not be split, chewed or crushed. The recommended storage temperature for the tablets is between 20-25°C. More information about the medication can be found on the website www.lomett.com.*
FDA Label Image

40 mg (Pantoprazole Sodium Delayed Release Tablets 3)

40 mg (Pantoprazole Sodium Delayed Release Tablets 3)
This is a description of a drug called Pantoprazole Sodium, which is available in tablet form. It is distributed by the company Pharmalis and comes in a pack with 90 tablets. Each tablet contains 20 mg of Pantoprazole and should not be chewed or crushed before use. The recommended dosage is not provided. The tablets must be stored within a temperature range of 15°C to 30°C (55°F to 86°F). The text suggests that it is important to refer to the accompanying information before use.*
FDA Label Image

Pantoprazole Sodium Delayed Release Tablets 4

Pantoprazole Sodium Delayed Release Tablets 4
This appears to be a prescription label or insert with dosage information for delayed-release tablets containing 40 mg of something, potentially called "pankoprzoke." It also includes a website for further information and storage instructions. There is not enough clear information to provide a more detailed description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.